Loading...
STERIS plc (STE) is not a strong buy at the moment for a beginner, long-term investor with $50,000-$100,000 available for investment. The technical indicators show no clear bullish trend, options data suggests mixed sentiment, and the company's financial performance shows declining revenue and gross margin. While net income and EPS have improved, the lack of positive catalysts, insider selling, and weak stock trend projections make this stock a hold rather than a buy.
The MACD is negative (-2.229) and contracting, RSI is neutral at 32.118, and moving averages are converging, indicating no clear trend. The stock is trading below the pivot level of 249.267, with support at 233.097 and resistance at 265.437.

Net income increased by 11.16% YoY, and EPS grew by 12.00% YoY in Q3 2026.
Revenue dropped by 43.17% YoY, gross margin declined significantly (-117.81% YoY), and insiders have increased selling activity by 17029.80% over the last month. No recent news or congress trading data is available to act as a positive catalyst.
In Q3 2026, revenue dropped significantly (-43.17% YoY) to $778.9M, while net income increased to $192.9M (+11.16% YoY). EPS improved to 1.96 (+12.00% YoY), but gross margin fell sharply to -7.93 (-117.81% YoY).
Recent analyst ratings are neutral, with Morgan Stanley maintaining an Equal Weight rating and JPMorgan maintaining a Neutral rating. Both analysts raised their price targets slightly, but the sentiment remains cautious.